USPTO

Electric vehicle Tesla Inc (NASDAQ:TSLA) giant has filed trademarks for "Robotaxi" and "Cybercab," two terms the company has used to describe its new autonomous vehicles. The bad news for Tesla is the United States Patent and Trademark Office said no to their trademark request. What Happened: With...

The U.S. Patent and Trademark Office has refused Tesla Inc.’s (NASDAQ:TSLA) attempt to trademark the term "Robotaxi." What Happened: The USPTO issued a ‘Nonfinal Office Action' notice to Elon Musk's company on Tuesday, a filing by the agency revealed. The agency said that it refused to grant...

Avicanna Inc. (OTCQX:AVCNF), a leading biopharmaceutical company specializing in plant-derived cannabinoid-based products, has announced the issuance of U.S. Patent No. US 20230025693A1 by the United States Patent and Trademark Office (USPTO). This patent covers Avicanna's deep penetrating topical...

In a recent development, Apple Inc. (NASDAQ:AAPL) is reportedly considering the introduction of interchangeable sleeves for its Apple Pencil. These sleeves could potentially provide users with enhanced controls, sensors, and extended battery life. What Happened: Apple filed new patent application...

The U.S. Patent and Trademark Office (USPTO) has issued a new patent granting IP rights for the novel composition of matter and methods of use on the psilocybin-based molecules series EVM301 to its developer, Enveric Biosciences (NASDAQ: ENVB).  The biotech company is advancing next-generation...

Biopharma company Silo Pharma Inc. (NASDAQ: SILO) filed a provisional patent application to the US Patent and Trading Office covering “methods and compositions for pain management” towards ameliorating pain, including chronic pain such as fibromyalgia, with its SP-26 program using a...

Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey. Reunion alleges that Mindset purposefully copied its psychedelic compound RE104...

Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders Psychedelics firm Silo Pharma Inc. (NASDAQ: SILO) has received a US patent covering claims on the use of proprietary ketamine-based drug SPC-15 for the treatment of stress-induced...

G Medical Innovations Holdings Ltd (NASDAQ: GMVD) shares are trading significantly higher Monday after the company announced it received notice of patent issuance from the United States Patent and Trademark Office (USPTO) for vital signs sensors. What Happened: G Medical...

Clinical-stage psychedelics drug development company Filament Health Corp. (OTCQB: FLHLF) has obtained two new patents for the extraction and standardization of natural psilocybin and associated psychedelic compounds by the USPTO.  Filament’s proprietary technology to extract and...

Former President Donald Trump is no stranger to legal troubles, with a past history of battles and current ones with the FBI and the White House. Trump’s SPAC deal to bring Trump Media & Technology Group with Digital World Acquisition Corp (NASDAQ: DWAC) has also faced challenges and...

Pharmaceutical films leader IntelGenx Corp. (OTCQB: IGXT) filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for advanced oral film formulations containing inventive claims of a non-combustible product alternative administering cannabinoids with a quicker...

Short-acting psychedelics biotech firm Small Pharma Inc. (OTCQB: DMTTF) received a USPTO patent protecting the composition matter of a group of deuterated DMT compounds, with expected exclusivity until April 2041.  “We have made significant strides this year progressing our research...

Biopharma R&D company Mindset Pharma Inc. (OTCQB: MSSTF) has performed preclinical screening studies and selected MSP-2020 as the lead psychedelic drug clinical candidate and MSP-2003 as the second backup drug candidate, both belonging to its Family 2 next-gen psychedelic drug program done in...

SEVALENT, Bexson Biomedical’s disrupting offer ready for the small molecule injectable market, received patent allowance by the USPTO for “Complexing Agent Salt Formulations of Pharmaceutical Compounds.”  The company’s formulation technology enables wearable, home...